New Observation on Androgen Action: Androgen Receptor Stabilization and Antisteroid Effects of LHRH Agonists

  • W. Wright
  • K. Chan
  • K. Sundaram
  • C. W. Bardin
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 138)

Abstract

The androgenic activity of testosterone and its 5c(-metabolites is classically defined as the growth promoting effect on the male reproductive tract. By contrast, the stimulatory effect of these hormones on nitrogen balance and body weight is referred to as their anabolic action (1). This latter effect results from androgen stimulation of protein synthesis in tissues, such as liver, kidney, bone and muscle, which compromise a major portion of body mass. Even though the anabolic and androgenic actions of testosterone were once thought to be distinct effects of a hormone, it is now clear that these are organ-specific responses. In most tissues, the effects of androgens are mediated via androgen receptors (2–4) and are inhibited by antiandrogens (5). In addition, the post-receptor actions of androgens are mediated via common intracellular events regardless of the tissue (6).

Keywords

Androgen Receptor Androgen Action LHRH Agonist Sodium Molybdate Testosterone Propionate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kochakian, C.D. Definition of androgens and protein anabolic steroids. Pharmac. Therap. B. 1: 149–177, 1975.Google Scholar
  2. 2.
    Bardin, C.W., Bullock, L.P., Mills, N.C., Lin, Y.-C. and Jacob, S.T. The role of receptors in the anabolic action of androgens. In: Receptors and Hormone Action, Vol. II, Chap. 4 (B.W. O’Malley, ed.), Academic Press, New York. pp. 83–103, 1978.Google Scholar
  3. 3.
    Bardin, C.W., Bullock, L.P., Sherins, R.J., Mowszowicz, I. and Blackburn, W.R. Androgen metabolism and mechanism of action in male pseudohermaphroditism: A study of testicular feminization. Rec. Prog. Horm. Res. 29: 65–109, 1973.PubMedGoogle Scholar
  4. 4.
    Bardin, C.W., Janne, O., Bullock, L.P. and Jacob, S.T. Physiochemical and biological properties of androgen receptors. In: Hormonal Regulation of Spermatogenesis (F.S. French, V. Hansson, E.M. Ritzen and S.N. Nayfeh, eds.), Plenum Press, New York. pp. 237–255, 1975.CrossRefGoogle Scholar
  5. 5.
    Mainwaring, W.I.P. Monographs on Endocrinology. The Mechanism of Action of Androgens, Vol. 10, Springer-Verlag, New York. 1977.CrossRefGoogle Scholar
  6. 6.
    Bardin, C.W., Brown, T.R., Mills, N.C., Gupta, C. and Bullock, L.P. The regulation of the B-glucuronidase gene by androgens and progestins. Biol. Reprod. 18: 74–83, 1978.PubMedCrossRefGoogle Scholar
  7. 7.
    Sundaram, K., Cao, Y.-Q., Rivier, J., Vale, W. and Bardin, C.W. Antisteroidal activity of LHRH agonists: A new biological effect. Nature(in press), 1980.Google Scholar
  8. 8.
    Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265–1951.PubMedGoogle Scholar
  9. 9.
    Bullock, L.P., Bardin, C.W. and Sherman, M.R. Androgenic, antiandrogenic, and synandrogenic actions of progestins: Role of steric and allosteric interactions with androgen receptors. Endocrinology 103: 1768–1782, 1978.PubMedCrossRefGoogle Scholar
  10. 10.
    Bonne, C. and Raynaud, J.-P. Methyltrienolone, a specific ligand for cellular androgen receptors. Steroids 26: 227–232, 1975.PubMedCrossRefGoogle Scholar
  11. 11.
    Bonne, C. and Raynaud, J.-P. Assay of androgen binding sites by exchange with methyltrienolone (R-1881). Steroids 27: 497–507, 1976.PubMedCrossRefGoogle Scholar
  12. 12.
    Zava, D.T., Landrum, B., Horowitz3, K.B. and McGuire, W.L. Androgen receptor assay with [3H]-methyltrienolone (R-1881) in the presence of progesterone receptors. Endocrinology 104: 1007–1012, 1979.PubMedCrossRefGoogle Scholar
  13. 13.
    Nielsen, C.J., Sando, J.J., Vogel, W.M. and Pratt, W.B. Glucocorticoid receptor inactivation under cell-free conditions. J. Biol. Chem. 252: 7568–7578, 1977.PubMedGoogle Scholar
  14. 14.
    Nielsen, C.J., Vogel, W.M. and Pratt, W.B. Inactivation of glucocorticoid receptors in cell-free preparations of rat liver. Cancer Res. 37: 3420–3426, 1977.PubMedGoogle Scholar
  15. 15.
    Sando, J.J., Hammond, N.D., Stratford, C.A. and Pratt, W.B. Activation of thymocyte glucocorticoid receptors to the steroid binding form. J. Biol. Chem. 254: 4779–4789, 1979.PubMedGoogle Scholar
  16. 16.
    Toft, D. and Nishigori, H. Stabi.li ation of the avian progesterone receptor by inhibitors. J. Steroid Biochem. 11: 413–416, 1979.PubMedCrossRefGoogle Scholar
  17. 17.
    Bullock, L.P. and Bardin, C.W. Androgen receptors in mouse kidney: A study of male, female and androgen-insensitive (Tfm/Y) mice. Endocrinology 94: 746–756, 1974.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • W. Wright
    • 1
  • K. Chan
    • 1
  • K. Sundaram
    • 1
  • C. W. Bardin
    • 1
  1. 1.The Population CouncilThe Rockefeller UniversityNew YorkUSA

Personalised recommendations